597 related articles for article (PubMed ID: 9724106)
21. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
22. Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma.
Ikeda H; Jokura H; Yoshimoto T
J Neurosurg; 2001 Aug; 95(2):285-91. PubMed ID: 11780899
[TBL] [Abstract][Full Text] [Related]
23. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
Sarkar S; Jacob KS; Pratheesh R; Chacko AG
Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
[TBL] [Abstract][Full Text] [Related]
24. Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study.
Shen M; Shou X; Wang Y; Zhang Z; Wu J; Mao Y; Li S; Zhao Y
Endocr J; 2010; 57(12):1035-44. PubMed ID: 21099129
[TBL] [Abstract][Full Text] [Related]
25. Significance of postoperative fluid diuresis in patients undergoing transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Zada G; Sivakumar W; Fishback D; Singer PA; Weiss MH
J Neurosurg; 2010 Apr; 112(4):744-9. PubMed ID: 19698049
[TBL] [Abstract][Full Text] [Related]
26. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C; Oearsakul T
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[TBL] [Abstract][Full Text] [Related]
28. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
[TBL] [Abstract][Full Text] [Related]
29. Outcome of Endoscopic Transsphenoidal Surgery for Acromegaly.
Kim JH; Hur KY; Lee JH; Lee JH; Se YB; Kim HI; Lee SH; Nam DH; Kim SY; Kim KW; Kong DS; Kim YH
World Neurosurg; 2017 Aug; 104():272-278. PubMed ID: 28465267
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP; Shin BJ; Mubita L; Huang C; Anand VK; Boockvar JA; Schwartz TH
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[TBL] [Abstract][Full Text] [Related]
31. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
[TBL] [Abstract][Full Text] [Related]
32. The common consensus criteria have high predictive values for long-term postoperative acromegaly remission.
Kristof RA; Grote A; Redel L; Neuloh G; Klingmüller D; Schramm J
Acta Neurochir (Wien); 2011 Jan; 153(1):19-25. PubMed ID: 20845050
[TBL] [Abstract][Full Text] [Related]
33. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
34. Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery.
McLaughlin N; Eisenberg AA; Cohan P; Chaloner CB; Kelly DF
J Neurosurg; 2013 Mar; 118(3):613-20. PubMed ID: 23240699
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery.
Yan JL; Chang CN; Chuang CC; Hsu PW; Lin JD; Wei KC; Lee ST; Tseng JK; Pai PC; Chen YL
J Formos Med Assoc; 2013 Jul; 112(7):416-20. PubMed ID: 23927981
[TBL] [Abstract][Full Text] [Related]
36. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
[TBL] [Abstract][Full Text] [Related]
37. Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery.
Lucas-Morante T; García-Uría J; Estrada J; Saucedo G; Cabello A; Alcañiz J; Barceló B
J Neurosurg; 1994 Jul; 81(1):10-4. PubMed ID: 8207509
[TBL] [Abstract][Full Text] [Related]
38. Transsphenoidal microsurgical removal of growth hormone-secreting pituitary adenomas. A review of 137 cases.
Baskin DS; Boggan JE; Wilson CB
J Neurosurg; 1982 May; 56(5):634-41. PubMed ID: 7069474
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Jul; 85(7):2476-82. PubMed ID: 10902796
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
Anik I; Cabuk B; Gokbel A; Selek A; Cetinarslan B; Anik Y; Ceylan S
World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
